{"id":2785,"date":"2025-02-03T15:39:17","date_gmt":"2025-02-03T12:39:17","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2785"},"modified":"2025-03-07T13:17:20","modified_gmt":"2025-03-07T10:17:20","slug":"entrada-therapeutics-receives-uk-authorization-to-begin-elevate-44-201","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/ru\/entrada-therapeutics-receives-uk-authorization-to-begin-elevate-44-201\/","title":{"rendered":"Entrada Therapeutics \u043f\u043e\u043b\u0443\u0447\u0430\u0435\u0442 \u0440\u0430\u0437\u0440\u0435\u0448\u0435\u043d\u0438\u0435 \u0412\u0435\u043b\u0438\u043a\u043e\u0431\u0440\u0438\u0442\u0430\u043d\u0438\u0438 \u043d\u0430 \u043d\u0430\u0447\u0430\u043b\u043e ELEVATE-44-201"},"content":{"rendered":"<p class=\"wp-block-paragraph\">ELEVATE-44-201, \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435 ENTR-601-44 \u0444\u0430\u0437\u044b 1\/2 \u0441 \u043c\u043d\u043e\u0433\u043e\u043a\u0440\u0430\u0442\u043d\u043e\u0439 \u0432\u043e\u0441\u0445\u043e\u0434\u044f\u0449\u0435\u0439 \u0434\u043e\u0437\u043e\u0439 (MAD), \u0431\u044b\u043b\u043e \u043e\u0434\u043e\u0431\u0440\u0435\u043d\u043e \u0410\u0433\u0435\u043d\u0442\u0441\u0442\u0432\u043e\u043c \u043f\u043e \u0440\u0435\u0433\u0443\u043b\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u044e \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0445 \u0441\u0440\u0435\u0434\u0441\u0442\u0432 \u0438 \u0438\u0437\u0434\u0435\u043b\u0438\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0433\u043e \u043d\u0430\u0437\u043d\u0430\u0447\u0435\u043d\u0438\u044f \u0412\u0435\u043b\u0438\u043a\u043e\u0431\u0440\u0438\u0442\u0430\u043d\u0438\u0438 (MHRA) \u0438 \u041a\u043e\u043c\u0438\u0442\u0435\u0442\u043e\u043c \u043f\u043e \u044d\u0442\u0438\u043a\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439 \u0434\u043b\u044f \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0438\u0441\u043f\u044b\u0442\u0430\u043d\u0438\u044f \u0438\u0441\u0441\u043b\u0435\u0434\u0443\u0435\u043c\u043e\u0433\u043e \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e \u043f\u0440\u043e\u0434\u0443\u043a\u0442\u0430. \u0426\u0435\u043b\u044c\u044e \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f \u044f\u0432\u043b\u044f\u0435\u0442\u0441\u044f \u043b\u0435\u0447\u0435\u043d\u0438\u0435 \u043c\u044b\u0448\u0435\u0447\u043d\u043e\u0439 \u0434\u0438\u0441\u0442\u0440\u043e\u0444\u0438\u0438 \u0414\u044e\u0448\u0435\u043d\u043d\u0430 (\u041c\u0414\u0414) \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u043f\u043e\u0434\u0442\u0432\u0435\u0440\u0436\u0434\u0435\u043d\u043d\u043e\u0439 \u043c\u0443\u0442\u0430\u0446\u0438\u0435\u0439 \u0432 \u0433\u0435\u043d\u0435 \u041c\u0414\u0414, \u043f\u043e\u0434\u0434\u0430\u044e\u0449\u0435\u0439\u0441\u044f \u043f\u0440\u043e\u043f\u0443\u0441\u043a\u0443 \u044d\u043a\u0437\u043e\u043d\u0430 44.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u0427\u0442\u043e \u0442\u0430\u043a\u043e\u0435 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435 ELEVATE-44-201?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">ELEVATE-44-201 \u2014 \u044d\u0442\u043e \u0433\u043b\u043e\u0431\u0430\u043b\u044c\u043d\u043e\u0435, \u0434\u0432\u0443\u0445\u044d\u0442\u0430\u043f\u043d\u043e\u0435, \u0440\u0430\u043d\u0434\u043e\u043c\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0435, \u0434\u0432\u043e\u0439\u043d\u043e\u0435 \u0441\u043b\u0435\u043f\u043e\u0435 \u043f\u043b\u0430\u0446\u0435\u0431\u043e-\u043a\u043e\u043d\u0442\u0440\u043e\u043b\u0438\u0440\u0443\u0435\u043c\u043e\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435 \u0444\u0430\u0437\u044b 1\/2, \u0432 \u043a\u043e\u0442\u043e\u0440\u043e\u043c \u043e\u0446\u0435\u043d\u0438\u0432\u0430\u0435\u0442\u0441\u044f \u0431\u0435\u0437\u043e\u043f\u0430\u0441\u043d\u043e\u0441\u0442\u044c, \u043f\u0435\u0440\u0435\u043d\u043e\u0441\u0438\u043c\u043e\u0441\u0442\u044c \u0438 \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u044c ENTR-601-44 \u0443 \u0430\u043c\u0431\u0443\u043b\u0430\u0442\u043e\u0440\u043d\u044b\u0445 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u041c\u0414\u0414, \u0443 \u043a\u043e\u0442\u043e\u0440\u044b\u0445 \u0432\u043e\u0437\u043c\u043e\u0436\u0435\u043d \u043f\u0440\u043e\u043f\u0443\u0441\u043a \u044d\u043a\u0437\u043e\u043d\u0430 44.<\/p>","protected":false},"excerpt":{"rendered":"<p>ELEVATE-44-201, a Phase 1\/2 multiple ascending dose (MAD) clinical study of ENTR-601-44, was authorized by the UK&#8217;s Medicines and Healthcare Products Regulatory Agency (MHRA) and Research Ethics Committee for the Clinical Trial of an Investigational Medicinal Product. The study aims to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation in the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2788,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[235,49,233,234,141,127,77,48],"class_list":["post-2785","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-elevate-44-201","tag-england","tag-entrada","tag-entrada-therapeutics","tag-exon-44","tag-exon-44-skipping","tag-exon-skipping","tag-uk"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/posts\/2785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/comments?post=2785"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/posts\/2785\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/media\/2788"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/media?parent=2785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/categories?post=2785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/ru\/wp-json\/wp\/v2\/tags?post=2785"}],"curies":[{"name":"WP","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}